Shanghai INT Medical Instruments to acquire 51.7% stake in Endonom Medical

Shanghai INT Medical Instruments Co., Ltd. will acquire a 51.7% stake in Endonom Medical (Hangzhou) for RMB 324 million (USD 45 million), as part of a joint acquisition of 81.83% with Shanghai Chenyue Weixin Medical Technology Co., Ltd.

“INT Med will obtain a 51.7% stake in Endonom Med for RMB 324 million (USD 45 million).”flcube.com

• 1 source
• flcube.comShanghai INT Medical Instruments to Acquire Majority Stake in Endonom Medical - Insight, China's Pharmaceutical IndustryFineline CubeMay 22, 2025

Summarized from public sources; check the original articles before acting on it.